Apotex Health (APTX) Stock Overview
Operates as a pharmaceutical manufacturing company in Canada, the United States, Mexico, and India. More details
| Snowflake Score | |
|---|---|
| Valuation | 3/6 |
| Future Growth | 4/6 |
| Past Performance | 2/6 |
| Financial Health | 2/6 |
| Dividends | 0/6 |
APTX Community Fair Values
Create NarrativeSee what others think this stock is worth. Follow their fair value or set your own to get alerts.
Join community and earn perks
Apotex Health Corp. Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | CA$35.94 |
| 52 Week High | CA$40.18 |
| 52 Week Low | CA$26.05 |
| Beta | 0 |
| 1 Month Change | 6.93% |
| 3 Month Change | n/a |
| 1 Year Change | n/a |
| 3 Year Change | n/a |
| 5 Year Change | n/a |
| Change since IPO | 33.11% |
Recent News & Updates
Recent updates
Shareholder Returns
| APTX | CA Pharmaceuticals | CA Market | |
|---|---|---|---|
| 7D | -4.3% | -1.5% | 0.6% |
| 1Y | n/a | 23.7% | 28.2% |
Return vs Industry: Insufficient data to determine how APTX performed against the Canadian Pharmaceuticals industry.
Return vs Market: Insufficient data to determine how APTX performed against the Canadian Market.
Price Volatility
| APTX volatility | |
|---|---|
| APTX Average Weekly Movement | 8.1% |
| Pharmaceuticals Industry Average Movement | 8.8% |
| Market Average Movement | 9.4% |
| 10% most volatile stocks in CA Market | 16.5% |
| 10% least volatile stocks in CA Market | 3.7% |
Stable Share Price: APTX has not had significant price volatility in the past 3 months compared to the Canadian market.
Volatility Over Time: Insufficient data to determine APTX's volatility change over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 1974 | 6,216 | Jeff Watson | www.apotex.com |
Apotex Health Corp. operates as a pharmaceutical manufacturing company in Canada, the United States, Mexico, and India. The company develops, manufactures, and distributes a broad portfolio of prescription and generic pharmaceuticals, oncology biosimilar pharmaceuticals, branded specialty pharmaceuticals, and branded consumer health and wellness products. It operates through three business lines including conventional generic pharmaceuticals; specialty generic pharmaceuticals; and brands & biosimilars.
Apotex Health Corp. Fundamentals Summary
| APTX fundamental statistics | |
|---|---|
| Market cap | CA$8.21b |
| Earnings (TTM) | CA$373.78m |
| Revenue (TTM) | CA$3.49b |
Is APTX overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| APTX income statement (TTM) | |
|---|---|
| Revenue | CA$3.49b |
| Cost of Revenue | CA$1.55b |
| Gross Profit | CA$1.94b |
| Other Expenses | CA$1.57b |
| Earnings | CA$373.78m |
Last Reported Earnings
Mar 31, 2026
Next Earnings Date
Aug 12, 2026
| Earnings per share (EPS) | 1.64 |
| Gross Margin | 55.65% |
| Net Profit Margin | 10.71% |
| Debt/Equity Ratio | -527.0% |
How did APTX perform over the long term?
See historical performance and comparisonCompany Analysis and Financial Data Status
| Data | Last Updated (UTC time) |
|---|---|
| Company Analysis | 2026/07/27 09:50 |
| End of Day Share Price | 2026/07/24 00:00 |
| Earnings | 2026/03/31 |
| Annual Earnings | 2026/03/31 |
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
| Package | Data | Timeframe | Example US Source * |
|---|---|---|---|
| Company Financials | 10 years |
| |
| Analyst Consensus Estimates | +3 years |
|
|
| Market Prices | 30 years |
| |
| Ownership | 10 years |
| |
| Management | 10 years |
| |
| Key Developments | 10 years |
|
* Example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.
Analyst Sources
Apotex Health Corp. is covered by 14 analysts. 13 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.
| Analyst | Institution |
|---|---|
| Frederico Yokota Choucair Gomes | ATB Cormark |
| David Martin | Bloom Burton & Co. |
| Evan Seigerman | BMO Capital Markets Equity Research |